Research collaboration to gasify compostable plastics into biochar soil using Georgia Tech's pressurized entrained flow reactor. The process aims to convert waste plastics into carbon-rich soil amendments superior to conventional crop soils, with catalytic gasification to break down inhibitory tars.
This research proposes a novel approach to circular plastic waste management by gasifying compostable plastics to produce biochar soil. The resulting soil amendment would be enriched with carbon black and supplemented with nutrients, potentially outperforming conventional crop soils used in the United States. The work addresses a critical question: whether heavy organic tars produced during gasification can be broken down into light gases and carbon, or whether catalytic gasification is required to prevent tars from inhibiting soil quality and plant growth.
The successful development of this process would create a valuable agricultural product from waste plastic streams, offering both a waste management solution and an enhanced soil product for agricultural applications.
Process approach:
Georgia Tech PEFR facility capabilities:
Validation methodology:
This research is at an early-to-mid stage of development. The gasification process itself is well-established for producing combustible gases and char carbon, but its specific application to producing biochar soil from compostable plastics requires validation. Key uncertainties include achieving char quality with tar and metal levels below thresholds that inhibit plant growth, and identifying cost-effective catalysts if needed. Future work includes greenhouse validation of plant growth performance and a preliminary techno-economic analysis to assess commercial viability.
Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.